Samreen Agha
Contributor since: 2014
Latest Articles
Organovo - Going The Right Direction
Disappointment Is Coming For Spectrum Pharmaceuticals
Bellicum Pharmaceuticals - Switch On To This
OPKO: Buy The Dip
Organovo: Slow And Steady Wins The Race
OPKO - Performing Consistently
Mobileye: An Autonomous Driving Leader
Lexicon Pharmaceuticals - A Diamond In The Rough?
Novavax - Buy The Dip For The Long Term
Sangamo BioSciences - Gene Therapy To Invest In
Update: NDA For Androxal Filed
Organovo: Better Times Ahead
Now May Be The Time To Buy Repros Therapeutics
OPKO Health: Time To Jump In For The Long-Term
Idera Pharmaceuticals Going Into 2015
Undervalued Argan Inc. Has Almost 62.5% Upside And Encouraging Growth Prospects
Idera Pharmaceuticals: A Star In The Making
Update: Organovo's FY2015 Second Quarter Results
Update: An Encouraging Third Quarter For Spectrum Pharmaceuticals
Update: AEterna Zentaris Q3 2014 Earnings
Organovo: Competition And Profit Potential
Recent Price Decline Creates An Attractive Entry Point For Halozyme
Aeterna Zentaris: A Risk Worth Taking
Spectrum Pharmaceuticals: A Long-Term Bet